GB202013571D0 - Injectable formulation - Google Patents
Injectable formulationInfo
- Publication number
- GB202013571D0 GB202013571D0 GBGB2013571.1A GB202013571A GB202013571D0 GB 202013571 D0 GB202013571 D0 GB 202013571D0 GB 202013571 A GB202013571 A GB 202013571A GB 202013571 D0 GB202013571 D0 GB 202013571D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- injectable formulation
- injectable
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2013571.1A GB202013571D0 (en) | 2020-08-28 | 2020-08-28 | Injectable formulation |
KR1020227042030A KR102636385B1 (en) | 2020-08-28 | 2021-08-20 | Injectable preparation |
EP21769080.9A EP4138818A1 (en) | 2020-08-28 | 2021-08-20 | Injectable formulation |
MX2022014128A MX2022014128A (en) | 2020-08-28 | 2021-08-20 | Injectable formulation. |
PCT/EP2021/073189 WO2022043227A1 (en) | 2020-08-28 | 2021-08-20 | Injectable formulation |
CA3179335A CA3179335C (en) | 2020-08-28 | 2021-08-20 | Injectable formulation |
CN202180044031.5A CN115701994B (en) | 2020-08-28 | 2021-08-20 | Injectable formulations |
IL298129A IL298129A (en) | 2020-08-28 | 2021-08-20 | Injectable formulation |
AU2021334933A AU2021334933B2 (en) | 2020-08-28 | 2021-08-20 | Injectable formulation |
JP2022577123A JP7422474B2 (en) | 2020-08-28 | 2021-08-20 | Injectable preparations |
BR112022022198-3A BR112022022198B1 (en) | 2020-08-28 | 2021-08-20 | INJECTABLE FORMULATION |
US17/459,284 US11406619B2 (en) | 2020-08-28 | 2021-08-27 | Injectable formulations |
US17/806,526 US20220313660A1 (en) | 2020-08-28 | 2022-06-13 | Injectable formulations |
ZA2023/01086A ZA202301086B (en) | 2020-08-28 | 2023-01-25 | Injectable formulation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2013571.1A GB202013571D0 (en) | 2020-08-28 | 2020-08-28 | Injectable formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202013571D0 true GB202013571D0 (en) | 2020-10-14 |
Family
ID=72749770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2013571.1A Ceased GB202013571D0 (en) | 2020-08-28 | 2020-08-28 | Injectable formulation |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202013571D0 (en) |
-
2020
- 2020-08-28 GB GBGB2013571.1A patent/GB202013571D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3890732A4 (en) | Injectable formulations | |
IL287628A (en) | Injectable pharmaceutical compositions and uses thereof | |
GB202007546D0 (en) | Formulation | |
GB201902551D0 (en) | Formulation | |
IL277802A (en) | Injectable composition | |
GB202013571D0 (en) | Injectable formulation | |
GB201913232D0 (en) | Aerosolisable formulation | |
EP3858377A4 (en) | Injectable composition | |
GB202113944D0 (en) | Injectable formulations | |
GB2599912B (en) | New formulation | |
ZA202102140B (en) | Sustained-release injectable antibiotical formulation | |
IL307849A (en) | Sotorasib formulation | |
IL308046A (en) | Alpelisib formulation | |
GB2595300B (en) | Novel Formulation | |
GB2595453B (en) | Novel Formulation | |
GB202108165D0 (en) | Formulation | |
GB202107439D0 (en) | Formulation | |
GB202107203D0 (en) | Formulation | |
GB202103970D0 (en) | Formulation | |
GB202102636D0 (en) | Formulation | |
GB202102408D0 (en) | Formulation | |
GB202016274D0 (en) | Formulation | |
ZA202105883B (en) | Ready-to-use injectable formulations | |
GB202010573D0 (en) | Formulation | |
GB202006008D0 (en) | Aerosolisable formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |